Compare AbbVie Inc (ABBV) vs Huntington Bancshares Incorporated (HBAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Huntington Bancshares Incorporated — how do they compare? AbbVie Inc trades at $249.74 (market cap $441.94B), while Huntington Bancshares Incorporated trades at $17.74 (market cap $35.93B). The key difference: AbbVie Inc is far larger — about 12.3× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| ABBV | HBAN | |
|---|---|---|
Market Cap | $441.94B | $35.93B |
Sector | Health | Financials |
52-Week High | $263.58 | $19.27 |
52-Week Low | $197.38 | $15.02 |
Enterprise Value | $506.19B | — |
Dividend Yield | 2.77% | 3.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.
Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.
HBAN trades at $17.60, up 0.28% today, with a bullish technical signal from moving averages and a consensus analyst price target of $19.78. Recent Q2 2026 earnings met estimates with EPS of $0.33, supported by net interest and fee income growth. The company targets an 18-19% ROTCE by 2027, though rising deposit costs present headwinds.
The outlook is cautiously optimistic, with valuation metrics like a P/E of 13.68 appearing reasonable. Upside potential exists if revenue growth and efficiency targets are met, but risks include margin pressure from higher funding costs and mixed earnings history. Institutional sentiment is balanced with 44.68% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →
